groups, systemic and local reactions were reported consistently less often in the accelerated schedule group. This suggests that the observed differences were due to the age difference between infants receiving each schedule.
Introduction
Non-radioactive in situ hybridisation has made it feasible to obtain cytogenetic information from interphase cells. In this technique chemically modified probe DNA, specific for a certain chromosome, is mixed with chromosomal DNA after denaturation to separate the double strands. After the probe and chromosomal DNA have combined the probe is conjugated with fluorescent molecules which can then be visualised by fluorescence microscopy.
Several studies have shown that non-radioactive in situ hybridisation with DNA probes can be used to study aberrations in the number of copies of chromosomes in cultured amniocytes. '4 We have previously reported the use of two centromere specific probes to determine the number of copies of chromosomes 1 and 18 in samples of uncultured amniocytes.4 Another study has described enumeration of the Y chromosome in uncultured amniocytes by in situ hybridisation with a probe specific for the long arm of this chromosome. 5 Similarly, we have found the centromere specific, chromosome X specific probe pBamX6 and a probe specific for a locus on the long arm of chromosome 1378 are suitable for in situ hybridisation on uncultured amniocytes (unpublished data).
In this preliminary study we used in situ hybridisation with a large probe specific for chromosome 21 to try to distinguish between samples of uncultured amniocytes with normal and trisomic karyotypes.
Materials and methods

CELLS
Amniotic fluids were sampled at 14-21 weeks' gestation from women at moderate risk of a fetus with chromosome abnormalities. Women carrying fetuses with karyotypically confirmed Down's syndrome had amniotic fluid drawn in conjunction with termination of pregnancy at 13-22 weeks' gestation. Informed consent was given by all the women. Amniocytes were isolated and prepared for in situ hybridisation as previously described.4 Twelve samples from fetuses with a normal karyotype and eight samples from fetuses with trisomy 21 were further analysed as described below.
Cultured amniocytes and mesenchymal cells from the chorionic villi were prepared by standard procedures and used for interphase and metaphase studies.
PROBES
The yeast artificial chromosome HY128 contains a human chromosome 21 specific DNA fragment of about 500000 base pairs. HY128 was obtained from M-C Potier and M Goedert (Medical Research Council, Cambridge, United Kingdom).
DNA from the HY128 yeast artificial chromosome and the host was used as the chromosome 21 probe and was prepared essentially as described by Burke and Olson.9 The probe was labelled with biotin-14-dATP (Bethesda Research Laboratories, Gaithersburg, Maryland, USA).
IN SITU HYBRIDISATION
In situ hybridisation with HY128 was done by using a modification of the procedure described by Pinkel et al.'0 Target DNA on slide mounted cells was denatured in 60% formamide, twice strength SSC buffer (normal strength SSC=0 15 M sodium chloride, 15 mM sodium citrate; pH 7-0) for 7 minutes at 80°C. Probe DNA was mixed 1:11 (w/w) with sonicated human placental DNA and desiccated under vacuum. The DNA was resuspended to a final concentration of 50 ng/4ld in a hybridisation mixture consisting of 50% formamide, twice strength SSPE buffer (normal strength SSPE=0 15 M sodium chloride, 10 mM sodium dehydrogen phosphate, 1 mM EDTA; pH 7-4), and 10% dextran sulphate. This solution was denatured at 70°C for 5 minutes and applied to cells on dry slides (3-2 gil/cm2). A coverslip was overlaid and sealed with rubber cement. Hybridisation was allowed to continue at 37°C in a humidified chamber for 36-60 hours. Slides were then washed in three changes of 50% formamide, twice strength SSC buffer at 45°C for 2 minutes each, twice in twice strength SSC buffer at room temperature for 5 minutes each, and once in Photomicrographs quadruple strength SSC buffer," 0 05% Tween 20 at room temperature for 5 minutes. Slides were then treated with alternating layers offluoresceinated avidin and biotinylated goat antiavidin both at 5 gig/ml in quadruple strength SSC buffer, 5% non-fat dry milk for 20 minutes each until two layers of avidin were applied. The avidin and antiavidin treatments were separated by three washes of 5 minutes each in quadruple strength SSC buffer, 0 05% Tween 20 (avidin-FITC and biotinylated antiavidin from Vector Laboratories, Burlingame, California, USA).
Slides were mounted in Tris glycerol buffer containing an antifading agent (1,4-diazabicyclo-(2,2,2)-octane (DABCO, Sigma, St Louis, Missouri, USA). The mounting medium contained either a blue (4',6-diamidine-2-phenylindole dihydrochloride (DAPI, Boehringer Mannheim, Penzberg, Germany) or a red DNA counterstain (propidium iodide).
Slides were examined with a Leitz Diaplan microscope equipped for fluorescein, DAPI, and propidium iodide fluorescence. Photomicrographs were all taken at 2800 times magnification on Kodak Ektar 1000 film.
BLIND STUDY DESIGN
All slides were evaluated quantitatively by the same blinded person. Because the number of squamous cells in amniotic fluid varies with gestational age'2 the normal and trisomic samples were collected at about the same gestational age range.
One 
REPRODUCIBILITY OF RESULTS
We have found that interobserver scoring variability is minimal at our laboratory.4 However the 3:2 ratio may vary from one laboratory to another because of the subjective scoring system. The scoring system was designed to address the occasional presence of split spots, attributed to DNA replication before cell division.'6 The subjectivity of the system may make scoring consistency difficult. In recent clinical studies using fluorescent hybridisation probes on uncultured amniocytes, analysis of data derived from a direct scoring protocol showed that the trisomic group did not overlap with the normal group (K W Klinger et al, personal communication). These results imply that the presence of split spots did not significantly affect the distinction between normal and trisomic samples. In future clinical studies direct counting criteria will be adopted to diminish scoring subjectivity.
This preliminary study was designed to determine the feasibility of detecting trisomy 21 in samples of uncultured amniocytes with a chromosome 21 specific probe. The analyses were done in conjunction with conventional chromosome analyses. 
